Sunday, November 17, 2019
Home > Business > New Device To Support Chronic Heart Disease Approved By The FDA

New Device To Support Chronic Heart Disease Approved By The FDA

New Device To Support Chronic Heart Disease Approved By The FDA

Chronic heart disease affects millions of people around the world and the prognosis of it is also not very good, with life expectancy reducing to 5 years after diagnosis and treatment. A new electrical device has been recently approved by the Food and Drug Administration for patients with hard to treat heart failures and it can bring a revolution in the well-being of such patients

The device called the Optimizer Smart System has been created by a company called Impulse Dynamics and its main function is to monitor the heartbeat of a person and send signals to the right mitral valve of the heart which is non-excitatory in nature. This device will benefit close to 5.7 million patients suffering from chronic heart disease in the US itself.

However, Impulse Dynamics could not be reached for comments regarding the same. Patients with the disease have a lot of physical limitations even after treatment and medications, which hampers their lifestyle. Even though the device is supposed to make it better for them, almost 70 percent of the patients are not suitable to receive it, according to reports by Impulse Dynamics itself.

Optimizer Smart System basically consists of an impulse generator which is surgically implanted under the skin, a charger for the battery, software and a programmer for it. According to the reports of the FDA, the generator is capable of providing electrical stimulus to the heart at regular intervals, which will facilitate the squeezing capacity. It may sound very similar to a pacemaker but it is different in its basic function itself as a pacemaker sets the rhythm of the organ whereas the OSS improves the contraction strength of the muscle.

The condition of people with OSS was monitored and found to be much better than the ones who resorted to only medications. The device will be launched in the US by this year while almost 3500 of them have been implanted in India, China, Brazil and different parts of Europe.

Leave a Reply

Your email address will not be published. Required fields are marked *